Phase I trial of docetaxel plus lutetium-177-labeled anti–prostate‐specific membrane antigen monoclonal antibody J591 (177Lu‐J591) for metastatic castration‐resistant prostate cancer

Document Details

Document Type
Pub Defense Publication
Publication Date
Nov 01, 2020
Source ID
10.1016/j.urolonc.2020.05.028

Entities

People

  • Ana M. Molina
  • Arif Sheikh
  • Charlene Thomas
  • David M. Nanus
  • Jaspreet S. Batra
  • Joseph R. Osborne
  • Muhammad Junaid Niaz
  • Neil H Bander
  • Paul Christos
  • Scott T Tagawa
  • Shankar Vallabhajosula
  • Young E. Whang
  • Yuliya S. Jhanwar

Organizations

  • National Institutes of Health
  • Prostate Cancer Foundation
  • United States Department of Defense